Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on October 2nd, 2025 | 07:25 CEST
AI fuels cancer research: Bayer, Vidac Pharma, and Pfizer are the next 150% winners
The stock market remains strong! In addition to the tech and defense boom, the biotech sector has also been catching up in recent days, with the latest news in cancer research bringing the industry back into the spotlight. The key factor here is artificial intelligence, which is revolutionizing cancer research through personalized therapy approaches based on the evaluation of extensive clinical and genetic data. AI models make it possible to predict individual cancer progression better and tailor therapies to individual patients. By analyzing multimodal data, AI systems can more accurately assess the risk of metastasis and thus develop targeted treatment strategies. AI has also improved tumor diagnostics by accurately detecting numerous types of cancer, therefore ensuring a more precise diagnosis.
Read
Commented by André Will-Laudien on October 2nd, 2025 | 06:55 CEST
Bitcoin Revolution 2025: How Strategy, MetaPlanet, Coinbase, Nakiki, and Palantir are redefining the market
With the rise of high-performance computers and new asset classes such as cryptocurrencies, liquidity is shifting to entirely new market segments. According to analysts, the global crypto market could swell to a volume of over EUR 10 trillion by 2030, driven by the mass adoption of tokens, DeFi, NFTs, and institutional capital. The greatest opportunities currently lie in asset management models betting on the long-term rise of Bitcoin & Co., with experts projecting annual growth rates exceeding 60%. On the NASDAQ, players such as Strategy and Coinbase are key drivers, while MetaPlanet is investing heavily in Asia. Now, Germany's Nakiki SE, the first pure Bitcoin treasury company, is entering the stage. A billion-dollar market is emerging – but the challenge lies in making the right choice.
Read
Commented by André Will-Laudien on September 30th, 2025 | 07:35 CEST
High-tech super boom! 1,000% no problem—here is more from D-Wave, NetraMark and Palantir!
Artificial intelligence (AI) is currently revolutionizing drug development by analyzing enormous amounts of data in a very short time and making clinical trials much more targeted. Modern AI systems make it possible to select drug candidates with precision and predict the potential success of a therapy with a high degree of accuracy. Companies like NetraMark are already using these technologies profitably. Players such as D-Wave and Palantir are also among the pioneers of the new AI-driven economy and have seen their share prices rise by over 1,000%. Expectations for further growth are virtually limitless. The advent of quantum computer technology also marks the beginning of a new chapter in ultra-fast data processing. For forward-looking investors, this opens up attractive entry opportunities in dynamically expanding future markets. Those who bet on the right players early on can benefit from this change to an above-average extent.
Read
Commented by André Will-Laudien on September 30th, 2025 | 07:10 CEST
Gold boom boosts critical metals! Another 100% with Power Metallic, BYD, Hensoldt and RENK
The geopolitical situation continues to escalate, but the stock markets continue to boom! Trade conflicts, sanctions, and military tensions dominate the headlines, but behind the front lines of a new Cold War, another competition has long been raging: the battle for access to critical metals. Without copper, lithium, nickel, cobalt, or rare earths, not only would the e-mobility revolution come to a standstill, but defense technologies, digitalization, and the energy transition would also grind to a halt. Supply chains are coming under increasing pressure from geopolitical power games, and the battle for resources is becoming a key strategic factor in a multipolar world order. For Western industrialized nations, security of supply is becoming a matter of survival, and for investors, this is creating new opportunities. Anyone looking for tomorrow's winners today should keep a close eye on the global raw materials poker game.
Read
Commented by André Will-Laudien on September 29th, 2025 | 07:20 CEST
Attention: Acquisitions! Biotechs like Evotec, PanGenomic Health, Pfizer, and BioNTech in focus
The biotech industry is in turmoil! With the expiration of blockbuster patents, there is a threat of sharp declines in revenue, which must be strategically compensated for. Driven by economic pressure and a growing focus on innovation and technology, the industry is increasingly turning to acquisitions of biotech companies with promising drug candidates, new technologies, and digital expertise. Not only are entire pipelines being acquired, but key players from the fastest-growing segments are also being targeted, particularly in the field of obesity therapies, where billions are being paid for drug candidates. Several examples illustrate this wave of transformation. Companies are restructuring, focusing their activities, and rapidly preparing for a phase of sustainable growth. The pace is picking up! Here are some promising investment ideas!
Read
Commented by André Will-Laudien on September 26th, 2025 | 08:20 CEST
Bitcoin at USD 250,000? Quantum computers conquer crypto – Favor D-Wave, Finexity and Alibaba now!
The financial markets are undergoing a profound transformation, with speed and computing power becoming decisive competitive advantages. High-performance computers have already revolutionized stock market trading by implementing complex strategies in milliseconds. At the same time, blockchain technology and crypto platforms are creating a new market that is benefiting massively from these technological developments. Whether in high-frequency trading, hedging digital assets, or building tokenized securities markets, the interplay of computing power and decentralized networks is opening up access to a whole new dimension of global financial flows. Which stocks offer opportunities?
Read
Commented by André Will-Laudien on September 26th, 2025 | 07:25 CEST
Shooting down Russian drones and fighter jets? NATO keeps its focus on Rheinmetall, Almonty and Hensoldt!
On the financial markets, Russian provocations involving jet and drone overflights are primarily perceived as a security risk. Such actions increase political instability and often trigger a flight to safe havens such as gold, government bonds, or the US dollar. At the same time, defense stocks and companies in the security sector tend to benefit, as investors anticipate rising defense spending in Europe and within NATO. For the broader equity market, the increased risk often translates into higher volatility and temporary price setbacks. In the long term, such threat scenarios are factored into risk premiums and valuation models, leading to more selective capital allocation in security-related sectors. Here are a few ideas.
Read
Commented by André Will-Laudien on September 26th, 2025 | 07:15 CEST
BioNxt Solutions – Biotech specialist with significant leverage in mega markets
Modern medicine faces an enormous challenge: More and more people are suffering from so-called diseases of affluence, such as obesity, diabetes, multiple sclerosis, and MASH, the dreaded fatty liver disease. At the same time, there is a growing need for innovative therapies and new dosage forms that make treatments more effective, simpler, and more patient-friendly. This is precisely where BioNxt Solutions comes in, a young biotech company that is addressing several billion-dollar markets with its patented thin-film technology. By enabling the oral administration of important active ingredients such as semaglutide and cladribine, BioNxt is not only opening up new therapeutic avenues but also significantly enhancing the effectiveness of existing drugs. At a time when pharmaceutical giants are investing billions in new solutions, BioNxt could become one of the most exciting future players in the industry.
Read
Commented by André Will-Laudien on September 22nd, 2025 | 07:30 CEST
E-mobility poised for the next boost! Focus now on Mercedes-Benz, Geely, BASF, and Graphano Energy!
The market for electric vehicles is heavily influenced by current battery technology. Advances in high-performance materials and solid-state batteries are significantly improving range, performance, and safety. Faster charging times and longer battery life are leading to greater consumer acceptance. The development of silicon anodes and new cathode materials is enabling more efficient and cost-effective batteries. Sustainable recycling methods are also important, as they strengthen the circular economy and reduce environmental impact. With the expansion of charging infrastructure, range anxiety is decreasing, and EV usage is becoming more convenient. This highly innovative environment opens up opportunities for both manufacturers and investors alike. Those who understand the key players in the space can achieve substantial returns.
Read
Commented by André Will-Laudien on September 22nd, 2025 | 07:20 CEST
SMR nuclear power on the rise! 100% with Oklo, First Hydrogen, E.ON, and Plug Power
Since Fukushima, nuclear power seemed to be on the decline, but with the energy transition, it is now experiencing a spectacular comeback, with small modular reactors (SMRs) taking center stage. Although this topic is only sporadically addressed in Europe, the US, under Donald Trump, recently approved a program to quadruple domestic nuclear power by 2050. While Brussels is still hesitating, the technology is advancing in Poland, France, Finland, and Czechia. These innovative countries are planning concrete SMR projects, while France even classifies the reactors as a pillar of future energy supply. Of course, large amounts of electricity are also supplied to Germany at high prices. Canada has already started approval processes for its first plants, and British energy giant Rolls-Royce is working on the series production of its own SMR technology. Even the International Atomic Energy Agency (IAEA) is now talking about a turning point. Which companies are currently at the forefront of this nuclear revolution?
Read